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Abstract
Background: Large numbers of Latin American immigrants recently arrived in Western Europe. Curative and preventive
programmes need to take account of their risk of suffering and transmitting imported chronic infections and of their
susceptibility to cosmopolitan infections. We aimed to assess the prevalence and co-occurrence of imported chronic
infections among Latin American immigrants, and their susceptibility to highly prevalent cosmopolitan infections.
Methods: Adult participants were recruited in the community and in a primary health centre in Geneva in 2008.
Serological tests were performed on stored sera for HIV, HBV, syphilis, Strongyloides stercoralis, Trypanosoma cruzi,
varicella and measles. We considered only chronic active infections in the analysis.
Results and discussion: The 1 012 participants, aged 37.2 (SD 11.3) years, were mostly female (82.5 %) and Bolivians
(48 %). Overall, 209 (20.7 %) had at least one and 27 (2.7 %) two or more chronic infections. T. cruzi (12.8 %)
and S. stercoralis (8.4 %) were the most prevalent chronic active infections compared to syphilis (0.4 %), HBV
(0.4 %) and HIV (1.4 %). Concomitant infections affected 28.2 and 18.5 % of T. cruzi and S. stercoralis infected
cases. Bolivian origin (aOR: 13.6; 95 % CI: 3.2–57.9) was associated with risk of multiple infections.
Susceptibilities for VZV and measles were 0.7 and 1.4 %, respectively. Latin American immigrants are at risk of
complications and possible reactivation of chronic parasitic infections but have overall low risks of chronic viral and
syphilitic active infections.
Conclusions: Systematic screening for chronic active parasitic infections is therefore necessary especially among
Bolivians. The high protection rate against measles and VZV doesn’t require specific preventive interventions.
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Multilingual abstracts
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Background
Recent decades have witnessed a sharp increase in trans-
national human mobility. In 2013, international migrants
stock amounted to 231 million (3.2 % of the world
population) with Europe hosting 72 million [1]. Latin
Americans (Latinos) represent a major group of immi-
grants in OECD countries, accounting for approximately
25 % of the total stock and their number has grown by
36 % in the past decade. It is estimated that around 4
millions recently settled in Western Europe [2]. While
the prevalence and incidence of non-communicable dis-
eases rapidly increase in Latin America, the burden of
communicable diseases remains a major public health
and economic problem [3].
Gradients in prevalence and susceptibility to specific
infectious diseases between immigrants and autochthon-
ous population impact on pathogens circulation in re-
ceiving countries and challenge healthcare systems to
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adapt to emerging needs [4]. For instance, the emer-
gence of Chagas disease in Europe has been shown to
result from (i) the rapid influx of people from endemic
countries, the majority being women of child-bearing
age susceptible to vertically transmit T. cruzi, (ii) insuffi-
cient pre-existing health policies, (iii) lack of health
professionals awareness and (iv) delayed responses of
healthcare systems [5, 6].
Previous studies showed that Latinos immigrants in
Europe bear a significant risk of chronic infections with
a potential of reactivation and transmission, such as
Chagas disease and latent tuberculosis [5, 7]. Coexisting
chronic infections in immigrants has triggered interest
because of the recognition of shared risk factors, pos-
sible clinical interactions, especially in presence of im-
munosuppression, and frequent delay in diagnosis [8, 9].
In Geneva for instance, the mean duration before Trypa-
nosoma cruzi infection (Chagas disease) was diagnosed
was 4.9 years, and 97.4 % patients were unaware of being
infected at time of diagnosis [10]. Chronic forms of
Hepatitis B [11], HIV [12], syphilis [13] and Strongy-
loides stercoralis [14] infections are more prevalent in
Latin America than in Western Europe. A better under-
standing of the activity, distribution and overlap of these
diseases within the Latino community in Europe is thus
necessary to implement appropriate clinical and public
health strategies.
Immigrants may also bear risks of suffering from and
enhancing transmission of highly prevalent cosmopolitan
infections when lacking specific immunity. Outbreaks of
rubella and chickenpox that predominantly affected
previously unexposed or non vaccinated immigrants in
Western countries exemplify this vulnerability [15, 16]. In
Switzerland, recent measles outbreaks have affected adult
Latino immigrants [17]. Varicella-zoster virus (VZV)
prevalence is lower in tropical countries than in Europe,
therefore immigrants arriving in Europe are at risk of pri-
mary infection [18]. Adult immunization is highly effective
in preventing potentially severe complications in persons
at risk. So far, the lack of data has hampered decision-
making about immunization programmes implementation
for Latino immigrants.
This study aims at assessing the prevalence and the
co-occurrence of HIV, hepatitis B, syphilis, S. stercoralis
and T. cruzi (Chagas disease) infection and the suscepti-
bility to varicella-zoster and measles virus among Latin
American immigrants in the community, and to compare
Bolivians to migrants from other origins.
Methods
Setting
Geneva Canton (population 480 000) hosts a community
of recently arrived immigrants from diverse Latin
American countries. Many live without residency permit
or health insurance and face difficulties accessing to
care. The Geneva University Hospitals (HUG) commu-
nity care centre is the gateway to the public healthcare
system for vulnerable immigrants. It provides preventive,
curative and rehabilitation care.
Design
This cross-sectional retrospective study used blood sam-
ples and demographic data collected during a Chagas
disease epidemiological survey conducted in 2008 [10].
It received ethical clearance from the Geneva University
Hospitals ethical board (protocol 07-285).
Participants and procedures
The study was implemented in the community, with the
support of Latino churches and social organizations, and
at the HUG community care centre. Cultural mediators
and documentation in Spanish were designed to maximize
participation. Eligible participants were all consecutive
adults (>16 year) Latino immigrants presenting at the
health centre or attending community meetings in
churches and cultural organizations between June and
December 2008. All participants provided detailed in-
formed consent that included the possible subsequent use
of collected sera for other infectious diseases diagnostic
studies. Pregnant women were excluded from this study
and referred to the Division of Obstetrics for another
study. Sociodemographic data were collected by question-
naire. Rural area was defined as living in a village or in any
non-urban setting in the campaign.
Serological testing
The analyses were performed in 2015 on serum samples
stored at −20 °C in the Geneva University Hospitals’ bio-
bank. After unfreezing, sera were tested for HIV 1 and 2
antibodies and p24 antigen (Architect HIV Ag/Ab Combo
assay, Abbott Laboratories, Abbott, USA). Positive results
were confirmed with VIDAS HIV Duo Quick assay (bio-
Mérieux, Marcy, France). Hepatitis B infection was assessed
first by testing for antibodies against core antigen (anti-
HBcAb) (Architect Anti-HBc Ig assay, Abbott) and then
for the surface antigen (HBsAg) (Architect HBsAg Qualita-
tive II assay, Abbott) in anti-HBc positive cases. Positive
HBsAg cases were reported as having chronic active Hepa-
titis B virus infection. The diagnostic algorithm for syphilis
(Treponema pallidum) was based on a treponemal ELISA
assay (Architect Syphilis TP, Abbott) as a first-line screen-
ing test. Positive samples were further tested with non-
treponemal (RPR-nosticon II, bioMérieux) and treponemal
(Cellognost-Syphilis TPHA assays, Siemens, Marburg,
Germany) assays. Syphilitic infection was considered in
presence of positive treponemal and non-treponemal
tests. Cases of positive TPHA with negative RPR testing
were not included in the final analysis, as indicative of
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cured or treated syphilis or rarely late latent syphilis.
Serological testing for S. stercoralis was performed with
an ELISA assay (Strongyloides ratti EIA, Bordier, Crissier,
Switzerland). Details on T. cruzi testing performed in
2008 are provided elsewhere [10]. Susceptibility to VZV
and measles virus infections was defined by negative
serological testing with Anti-VZV/IgG assay (Virion
Labordiagnostik, Zürich, Switzerland) and Anti-Measles
Enzygnost /IgG (Siemens), respectively. Borderline and
positive results were further tested with VIDAS varicella-
zoster (IgG) and VIDAS Meales (IgG) (bioMérieux) con-
firmatory tests. Co-infection was considered in presence
of more than one infection.
Statistical analysis
Categorical data were presented as absolute numbers
and proportions, and continuous variables as mean and
standard deviation (SD). To investigate the relation be-
tween co-infection, respectively S. strongyloides infec-
tion, and possible predictive factors, we used 2 × 2 tables
and performed chi-square and Fisher’s exact tests for
categorical variables and unpaired Student’s t-tests for
continuous variables. Univariate and multivariate logistic
regression analysis were used to assess factors associated
with co-infection respectively S. strongyloides infection.
Adjustment was performed for age, sex, coming from
rural vs. urban area, Bolivian origin and having left Latin
America since 5 years. Data were analysed using IBM
SPSS Statistics (version 23).
Results
Participants
Overall, 1 012 participants were included with a mean age
of 37.2 (SD 11.3) years, a female predominance (83 %) and
origin from 17 countries. The most frequently origins
were Bolivia (n=486; 48 %), Brazil (n=249; 25 %),
Colombia (n=61; 6 %), Peru (n=58; 6 %) and Ecuador
(n=47; 5 %).
Serological tests results
Table 1 summarizes the participants’ socio-demographic
characteristics and the serological tests results stratified
by origin. We found a 12.8 and 8.4 % prevalence of
chronic parasitic infections with T. cruzi and S. stercora-
lis. Details about T. cruzi infection were published else-
where [10]. Importantly, it was more frequent in
Bolivians than in participants from other origins (26.1 %
versus 0.6 %, P <0.001). After adjustment, risk factors for
S. stercoralis infection included male gender, Bolivian
origin and shorter duration of stay in Europe (Table 2).
Global HIV prevalence was 1.4 % with non-Bolivian
being more frequently infected (P <0.05). Regarding
hepatitis B, 7.4 % participants had anti-HBc antibodies
while 0.4 % had a positive test for HBs antigen, indica-
tive of active infection. Overall, 2.4 % had serologic
markers of cured syphilis while 0.4 % had positive trepo-
nemal and non treponemal tests indicating active infec-
tion. Rates did not differ between Bolivians and others.
Susceptibility to VZV and measles were 0.7 and 1.4 %.
Measles immunity decreased with younger age. Nine out
Table 1 Sociodemographic characteristics, prevalence of infection and susceptibility to local infections of the total population
(n=1012) and stratified by origin
Total population (n=1012) Bolivians (n=486) Other origin (n=526) P- value
Mean (SD) or n (%) Mean (SD) or n (%) Mean (SD) or n (%)
Age 37.4 (11.3) 36.5 (10.8) 38.3 (11.7) 0.01
Sex (female) 835 (82.5 %) 404 (83.1 %) 431 (81.9 %) 0.62
Coming from urban area 813 (80.3 %) 373 (76.7 %) 440 (83.7 %) 0.007
Years since arrival in Europe 4.9 (4) 4.5 (2.9) 5.3 (4.8) 0.001
Prevalence of infections
HIV 14 (1.4 %) 3 (0.6 %) 12 (2.3 %) 0.04
HBV (anti-HBc Ab+) 75 (7.4 %) 40 (8.2 %) 35 (6.7 %) 0.40
HBV (HBsAg+) 4 (0.4 %) 2 (0.4 %) 2 (0.4 %) 1
Syphilis (any reactive test) 24 (2.4 %) 9 (1.9 %) 15 (2.9 %) 0.66
Syphilis infection 4 (0.4 %) 2 (0.4 %) 2 (0.4 %) 1
T. cruzi 130 (12.8 %) 127 (26.1 %) 3 (0.6 %) <0.001
S. stercoralis 85 (8.4 %) 65 (13.4 %) 20 (3.8 %) <0.001
Susceptibility to cosmopolitan infections:
VZV susceptibility 7 (0.7 %) 1 (0.2 %) 7 (1.1 %) 0.126
Measles susceptibility 14 (1.4 %) 4 (0.8 %) 10 (1.9 %) 0.181
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of 252 persons (3.6 %) born after 1980 were susceptible
to measles, whereas five out of 760 (0.7 %) older ones
were susceptible (P <0.001).
One or more chronic active infections were found in
209 participants (20.7 %) with a majority presenting only
one infection. Twenty-seven (2.7 %) had two or more in-
fections (Table 3). Of those, 24 were co-infected with T.
cruzi and S. stercoralis, which meant 18.5 % of T. cruzi
infected participants presented S. strongyloides co-
infection and 28.2 % vice versa. Only two (14 %) of the
14 HIV patients presented with a co-infection.
Factors associated with infection
Tables 4 and 5 show factors associated with infection
overall and with multiple infections. After adjustment,
age, male gender, Bolivian and rural origin were predic-
tors of infection. Bolivian and rural origin were signifi-
cantly associated with multiple infections, but only the
former remained significant after adjustment for the
other factors.
Discussion
This community-based study showed that 20.7 % Latinos
in Geneva suffered from one or more chronic infections
with a risk of reactivation and of transmission. Infection
with T. cruzi and S. stercoralis accounted for the heaviest
burden in this predominantly Bolivian population,
whereas HIV, HBV and syphilis were less frequent. Age,
male gender, rural and Bolivian origin predicted the risk
of suffering of at least one chronic infection, and Bolivians
were at higher risk of multiple infections. Immigrants
showed high protection rates against highly prevalent
cosmopolitan infections such as VZV and measles.
Several limitations should be considered. The first per-
tains to the predominant Bolivian population reflecting
the distribution of Latino immigrants in Geneva. In
Europe, immigrants from Ecuador, Colombia, Peru,
Brazil and Argentina are more numerous [2]. The high
prevalence of Chagas disease in Bolivia skewed our re-
sults about co-infections rates, as T. cruzi accounted for
the major cause of infection in our sample. Therefore,
studies conducted with immigrants of other origins may
entail different results. Secondly, albeit cold storage,
sample handling and serological tests have been per-
formed under optimal conditions, we cannot exclude
that these conditions impacted on the reactivity of some
sera stored for 6 years. Moreover, the use of a single
diagnostic test for S. stercoralis may entail a limited risk
of suboptimal discrimination capacity between recently
treated and current infection [19]. Thirdly, we restricted
our study to a limited number of pathogens. Prevalence
of other pathogens causing chronic infection in Latino
immigrants Europe, such as Schistosoma spp, Leish-
mania spp, Plasmodium spp, Hepatitis C and HTLV,
have been shown to be very low and of limited clinical
and public health significance [20–23]. We cannot
exclude that some participants presented with other
chronic infections, notably latent tuberculosis [20]. Fi-
nally, women were over-represented in our sample,
whereas genders are equally represented among Latino
immigrants in Europe [2]. Considering that males
Table 2 Factors associated with Strongyloides stercoralis
infection (n=1012)
Factor OR (95 % CI) OR adjusteda (95 % CI)
Age >35 1.08 (0.69–1.69) 1.41 (0.88–2.25)
Male 1.86 (1.12–3.10) 2.06 (1.21–3.51)
Bolivian origin 3.91 (2.33–6.55) 3.83 (2.27–6.47)
Coming from a rural area 1.69 (1.03–2.79) 1.59 (0.95–2.68)
Less than 5 years out of
Latin America
2.10 (1.29–3.40) 2.18 (1.32–3.62)
aAdjusted for all factors in table










0 803 (79.3 %) 313 (64.4 %) 490 (93.1 %)
1 182 (18 %) 148 (30.5 %) 34 (6.5 %)
2 26 (2.6 %) 24 (4.9 %) 2 (0.4 %)
3 1 (0.1 %) 1 (0.2 %) 0 (0 %)
≥1 209 (20.7 %) 173 (35.6 %) 36 (6.8 %)
Table 4 Factors associated with infection (n=209)
Factor OR (95 % CI) OR adjusteda
(95 % CI)
Age >35 1.85 (1.35–2.53) 2.50 (1.75–3.57)
Male 1.40 (0.96–2.04) 1.78 (1.17–2.73)
Bolivian origin 7.52 (5.11–11.07) 8.09 (5.44–12.03)
Rural origin 1.80 (1.27–2.57) 1.62 (1.09–2.39)
Less than 5 years out of
Latin America
1.20 (0.88–1.63) 1.39 (0.98–1.97)
aAdjusted for all factors in table
Table 5 Factors associated with multiple infections (n=27)
Factor OR (95 % CI) OR adjusteda
(95 % CI)
Age >35 1.20 (0.56–2.59) 1.42 (0.64–3.19)
Male 1.68 (0.70–4.03) 1.91 (0.78–4.70)
Bolivian origin 14.21 (3.35–60.31) 13.59 (3.19–57.91)
Rural origin 2.48 (1.12–5.50) 2.14 (0.95–4.84)
Less than 5 years out of
Latin America
1.41 (0.64–3.12) 1.42 (0.62–3.24)
aAdjusted for all factors in table
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tended to have more risk of multiple infections (notably
with S. stercoralis), the proportion of co-infections might
be higher in settings with a more balanced distribution.
This study investigated the largest sample of Latinos
immigrants in Europe so far. The community-based re-
cruitment and the restriction to infections at the chronic
stages offer new clinical and epidemiological insights.
For instance, the difference between the 2.4 % overall
syphilis seroreactivity in Geneva, with 0.4 % showing
active infection, compared to 3.5–6.4 % in Spain, likely
reflect the population-based sample as opposed to more
selective samples in other studies [7, 20, 24]. In our sam-
ple, HBV prevalence was slightly lower than reported in
previous studies likely for similar reasons [7, 20, 25]. Dif-
ferences were less marked regarding HIV prevalence,
which is consistently low among Latinos in Europe as
compared to other immigrants groups [7, 20, 22, 26].
Our findings do not support recent recommendations to
systematically screen asymptomatic Latino immigrants
for HIV, syphilis and HBV [21]. We rather suggest tailor-
ing screening strategies according to individual risk
assessment for these pathogens.
Studies conducted in Italy and Spain with large popu-
lations of Bolivian immigrants have consistently reported
comparably high prevalence of T. cruzi infection, con-
firming that this group bears the highest burden of
infection among Latino immigrants [27, 28]. This sup-
ports universal screening in Bolivian immigrants with a
focus on groups at higher risk of transmission or com-
plication or higher chance of successful treatment, such
as child-bearing age or pregnant women, people with
immunosuppression, newborns and children.
We found an overall 8.4 % prevalence of S. stercoralis
infection in our population, with Bolivians, from rural
origin and men showing the highest rates, which corre-
lates with community studies conducted in Latin America
[29]. To the best of our knowledge, this is the first
community-based survey among Latinos in Europe.
Ramos et al. found 26.8 % of Latino patients of a tertiary
hospital in Spain being infected, with Ecuadorians
showing highest risk of infection [22]. A study among
HIV-infected Latinos in Italy showed 6.7 % prevalence
[30]. We found frequent parasitic co-infections between
T. cruzi (18.5 %) and S. stercoralis (28.2 %) confirming
previous findings from Italy [31]. In our analysis, male
gender, Bolivian origin and shorter duration of stay were
positively associated with infection. The lack of significant
association with rural origin may pertain to a limited
study power. Adding to the current practice of
screening Latinos with eosinophilia for S. stercoralis,
our findings support systematic detection of immi-
grants at risk, notably Bolivians, for both parasites.
Moreover, screening for infection in persons with on-
going or risk of immunosuppression before initiating
steroid therapy and chemotherapy is essential to pre-
vent the occurrence of hyper infestation [30].
Our data showed low susceptibility to measles and
varicella-zoster infection in Latinos. This is of epidemio-
logical and clinical relevance considering the community
circulation of these pathogens in Switzerland and that
most participants were women of child-bearing age and
predominantly active in the domestic work industry. The
98.6 % protection against measles is actually higher than
among Geneva residents [17]. We found younger immi-
grants being slightly more susceptible. In absence of com-
parative data in Europe, we cannot ascertain this finding is
generalizable to neighbouring countries. In 2004, Latino
immigrants in Canada had an overall 88 % protection rate,
with women more at risk of infection than men [32].
Immunization campaigns implemented in Latin America
in the 1980’s sharply reducing the virus circulation and the
incidence [33]. Therefore, we can safely consider that adult
Latino immigrants, especially those borne before 1980 are
at very low risk for measles in Switzerland and do not need
systematic screening or catch-up immunization. However,
as measles is no longer circulating in Latin America, un-
vaccinated children and young adults originating from
countries characterized by suboptimal vaccination coverage
must be considered susceptible. Regarding VZV, we found
higher rates of protection than previously reported
among immigrants from Surinam and the Antilles in
the Netherlands and HIV infected immigrants in Spain
[34, 35]. In Catalonia, Valerio et al. found a two-fold in-
crease in VZV infection incidence rate among Latino adults
compared to Spanish [36]. Yet, our findings call against
implementation of systematic screening in this group but
rather supports the current strategy of screening and im-
munizing immunosuppressed adults and providing post-
exposure prophylaxis to pregnant women [37]. Further
studies are needed to evaluate immigrants’ susceptibility to
other local frequently acquired and vaccine-preventable in-
fections such as pertussis.
Conclusions
In summary, our findings support the need to systematic-
ally screen adult Latin American immigrants, especially
Bolivians, against chronic parasitic infections and to tailor
screening strategies for other infections and susceptibility
to measles and VZV after individual risk assessment.
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